pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
FATE THERAPEUTICS INC ($FATE) · news · pharmadog
← back to FATE THERAPEUTICS INC
News mentioning $FATE
38
stories
9d
This week in charts: Brain drugs are back on venture capitalists’ minds
biopharma dive
11d
Despite midterm losses, RFK Jr. is bullish on MAHA's future
endpoints
15d
Democrats’ midterm victory, and a questionable fertility procedure
stat
17d
STAT+: A closer look at ProMis Neurosciences and its Alzheimer’s drug
stat
17d
STAT+: Where does MAHA go from here? 3 possible futures
stat
17d
Sanofi’s axing of Nurix STAT6 program ‘not a target-related issue’
biospace
23d
STAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA
stat
25d
‘The patient need is enormous’: Syntax programs stem cells into pancreatic beta cells in 4 days
fiercebiotech
Oct 19, 26
From cells to organoids: Cytokines that shape 3D culture
biospace
Oct 15, 26
The Trump administration is doubling down on health care fraud investigations
stat
Oct 15, 26
Rebranded Galapagos finally finds buyer for unwanted cell therapy pipeline
fiercebiotech
Oct 13, 26
Opinion: Lethal injection will never be the same after Christa Pike’s botched execution
stat
Oct 11, 26
The 2026 Biotech Graveyard
fiercebiotech
Oct 8, 26
In the hunt for reverse merger targets, Caribou could be prized game
biopharma dive
Oct 7, 26
Cadrenal launches strategic review for late-stage cardiology pipeline
fiercebiotech
Oct 7, 26
iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa
fiercebiotech
Sep 3, 26
Capricor, Replimune illustrate why FDA must listen to rare disease specialists
biospace
Sep 2, 26
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
biopharma dive
Sep 2, 26
UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy
biopharma dive
Sep 1, 26
As MAHA champions nutrition, it’s ignoring the experts, dietitians say
stat
Aug 31, 26
UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies
fiercebiotech
Aug 21, 26
Capricor investor calls for change as company awaits decision on Duchenne candidate
biospace
Aug 21, 26
Scientists deploy Merck’s Ebola vaccine in DRC
stat
Aug 20, 26
Scribe’s early-stage IPO standout defies biotech’s derisking trend
biospace
Aug 20, 26
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
stat
Aug 18, 26
Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss
fiercebiotech
Aug 14, 26
Capricor soars on potential FDA review extension, filing amendments
biospace
Jul 30, 26
Key Senate panel backs Trump’s picks for CDC, pandemic preparedness
stat
Jul 28, 26
FDA reminds investors about the risks of advisory panels
endpoints
Jul 28, 26
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
stat
← prev
page 1 of 2
next →